DARE
#4672
Dare Bioscience, Inc. - Common Stock
0.7 8 USD
+0.05%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+5.41%
Changement Mensuel
+2.63%
Evolution sur 6 mois
-50.63%
Changement Annuel
-52.73%
Clôture Précédente
0.7 4
Open
0.7 8
Low
0.7 8
High
0.7 8
Volume
2
Financials
- Market Capitalization 11.93 M
- Employee 24
- Founded 2005
- CEO Sabrina Martucci Johnson
- Website www.darebioscience.com
- Headquarter Delaware, United States
- FIGI BBG001J2P362
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.61
ratio cours/chiffre d'affaires
20.94
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4669 |  VTGN Vistagen Therapeutics, Inc. - Common Stock | 0.27 USD | -10.00% | +12.50% | +3.85% | -47.58% | 11.98 M USD | ||
| 4671 |  ASBP Aspire Biopharma Holdings, Inc. - Common Stock | 8.51 USD | -2.18% | -3.95% | +0.24% | +445.51% | 11.94 M USD | ||
| 4674 |  INAB IN8bio, Inc. - Common Stock | 1.20 USD | 0.00% | +10.09% | +18.81% | -28.14% | 11.83 M USD | ||
| 4677 |  PHIO Phio Pharmaceuticals Corp. - Common Stock | 1.01 USD | -0.98% | -3.81% | -10.62% | -15.13% | 11.73 M USD |